Vanquest Pharma Private Limited, a active private limited company, was established on 12 June 2019 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24304MH2019PTC326607. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Employing 134 professional, Its leadership includes Pavan H Patel (Director), Hiten Patel (Director), Manish Babulal Jain (Director). Past directors included Kamala Babulal Jain, Babulal Kesharimal Jain. It holds ₹60.00 Cr open charges and ₹53.20 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 208 Town Centre Comm Prem Coop Soc Ltd, Nr Mahalaxmi Andheri East, Mumbai, Maharashtra, 400059.
U24304MH2019PTC326607
326607
12 June 2019
₹1.00 Cr
₹1.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Vanquest Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pavan H Patel | Director | 12 Jun 2019 | Current |
| Hiten Patel | Director | 12 Jun 2019 | Current |
| Manish Babulal Jain | Director | 12 Jun 2019 | Current |
| Mohan Babulal Jain | Director | 12 Jun 2019 | Current |
| Pratik Hitenkumar Patel | Director | 12 Jun 2019 | Current |
| Aarya Mohan Jain | Additional Director | 26 Mar 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Mar 2025 | Past |
| Pramod Abcsdd | Director | 08 Jan 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vanquest Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 420.15% increase. The company also saw a substantial fall in profitability, with a 726.14% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1232.87%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Vanquest Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹600,000,000.00
₹532,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Mar 2024 | Others | ₹60.00 Cr | Open |
| 27 Aug 2021 | Others | ₹53.20 Cr | Satisfied |
Explore comprehensive loan charge details -
Vanquest Pharma has a workforce of 134 employees as of Apr 05, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Vanquest Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vanquest Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Aarya Mohan Jain was appointed as a Additional Director was appointed as a Additional Director on 26 Mar 2025 & has been associated with this company since 8 months . was documented.
Progress on Vanquest Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity A charge with Others of Rs. 60.00 Cr registered on 26 Mar 2024 with Charge ID 100889207 was modified on 16 May 2024. was completed.
Progress on A charge registered on 27 Aug 2021 via Charge ID 100479800 with Others was fully satisfied on 18 Apr 2024. was documented.
Vanquest Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 60.00 Cr with Charge ID 100889207 was registered on 26 Mar 2024. was documented.
The CIN of Vanquest Pharma Private Limited is U24304MH2019PTC326607.
Vanquest Pharma Private Limited is headquartered at 208 Town Centre Comm Prem Coop Soc Ltd, Nr Mahalaxmi Andheri East, Mumbai, Maharashtra, 400059.
Vanquest Pharma Private Limited was incorporated on 12 June 2019.
The current directors of Vanquest Pharma Private Limited are
The primary industry of Vanquest Pharma Private Limited is Manufacturing.
Vanquest Pharma Private Limited is unlisted.
The authorized capital of Vanquest Pharma Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Vanquest Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX